SUPN
Supernus Pharmaceuticals Inc
28.20$
-32.8%
vs. previous close
Closing price · As of: Nov 3, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Supernus Pharmaceuticals Inc (SUPN) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 11/02/2026 | Current report (8-K) | SUPERNUS PHARMACEUTICALS, INC. (SUPN): Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | View report ↗ |
| 11/02/2026 | Current report (8-K) | SUPERNUS PHARMACEUTICALS, INC. (SUPN): Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Material Modifications to Rights of Security Holders; Changes in Control of Registrant; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Regulation FD Disclosure; Financial Statements and Exhibits | View report ↗ |
| 10/29/2026 | Current report (8-K) | SUPERNUS PHARMACEUTICALS, INC. (SUPN): Results of Operations and Financial Condition; Financial Statements and Exhibits | View report ↗ |
| 10/26/2026 | Current report (8-K) | SUPERNUS PHARMACEUTICALS, INC. (SUPN): Termination of a Material Definitive Agreement; Financial Statements and Exhibits | View report ↗ |
| 10/22/2026 | Current report (8-K) | SUPERNUS PHARMACEUTICALS, INC. (SUPN): Other Events; Financial Statements and Exhibits | View report ↗ |
| 10/19/2026 | Current report (8-K) | SUPERNUS PHARMACEUTICALS, INC. (SUPN): Results of Operations and Financial Condition | View report ↗ |
| 10/15/2026 | Current report (8-K) | SUPERNUS PHARMACEUTICALS, INC. (SUPN): Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits | View report ↗ |
| 08/03/2026 | Current report (8-K) | SUPERNUS PHARMACEUTICALS, INC. (SUPN): Other Events; Financial Statements and Exhibits | View report ↗ |
| 08/03/2026 | Current report (8-K) | SUPERNUS PHARMACEUTICALS, INC. (SUPN): Other Events; Financial Statements and Exhibits | View report ↗ |
| 08/03/2026 | Current report (8-K) | SUPERNUS PHARMACEUTICALS, INC. (SUPN): Results of Operations and Financial Condition; Financial Statements and Exhibits | View report ↗ |
| 08/03/2026 | Current report (8-K) | SUPERNUS PHARMACEUTICALS, INC. (SUPN): Entry into a Material Definitive Agreement; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Other Events; Financial Statements and Exhibits | View report ↗ |
| 07/22/2026 | Current report (8-K) | SUPERNUS PHARMACEUTICALS, INC. (SUPN): Results of Operations and Financial Condition; Financial Statements and Exhibits | View report ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: November 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.